Category BUSINESS

Arrowhead Pharmaceuticals Finalizes Global Licensing and Collaboration Deal with Novartis

Arrowhead Pharmaceuticals Announces Completion of Global Licensing and Collaboration Agreement with Novartis Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a leading biopharmaceutical company focused on developing innovative RNA interference (RNAi) therapeutics, announced today that its previously disclosed global licensing and collaboration agreement…

Read MoreArrowhead Pharmaceuticals Finalizes Global Licensing and Collaboration Deal with Novartis

Merck Publishes Long-Term Phase 3 Data on OGSIVEO® (nirogacestat) for Desmoid Tumors in Journal of Clinical Oncology

Merck Publishes Long-Term Phase 3 DeFi Trial Results Demonstrating Sustained Efficacy and Safety of OGSIVEO® (nirogacestat) for Desmoid Tumors in Journal of Clinical Oncology Merck, a leading science and technology company, announced the publication of long-term efficacy and safety findings…

Read MoreMerck Publishes Long-Term Phase 3 Data on OGSIVEO® (nirogacestat) for Desmoid Tumors in Journal of Clinical Oncology

Materion Corporation Schedules Third Quarter 2025 Financial Results Announcement for October 29

Materion Corporation to Announce Third Quarter 2025 Financial Results on October 29, 2025 Materion Corporation (NYSE: MTRN), a leading global provider of advanced materials solutions, has announced that it will release its financial results for the third quarter of 2025…

Read MoreMaterion Corporation Schedules Third Quarter 2025 Financial Results Announcement for October 29

Ashland Expands Injectables Portfolio with High-Purity Sucrose and Low-Nitrite Excipients

Ashland is spotlighting multiple new and optimized pharmaceutical product offerings during CPHI Frankfurt, October 28-30 (booth 8.0Q48) and AAPS PharmSci 360, San Antonio, TX, November 9-12 (booth 2808). To respond to global customer needs, Ashland has introduced vialose™ sucrose, a…

Read MoreAshland Expands Injectables Portfolio with High-Purity Sucrose and Low-Nitrite Excipients

BASF Opens NPG Plant in Zhanjiang, Launches Low-Carbon NEOL® NPG

BASF expands its presence in China with a new high-efficiency NPG plant powered by renewable energy, delivering lower-carbon intermediates for eco-friendly coatings BASF’s Intermediates division has inaugurated a new neopentyl glycol (NPG) plant at the Verbund site in Zhanjiang, China. Following the start-up of the new plant with an annual production…

Read MoreBASF Opens NPG Plant in Zhanjiang, Launches Low-Carbon NEOL® NPG

Air Products Completes First Liquid Hydrogen Fill at World’s Largest Sphere at NASA

Air Products Completes Historic First Liquid Hydrogen Fill of World’s Largest Storage Sphere at NASA’s Kennedy Space Center Air Products (NYSE: APD), the global leader in hydrogen supply, announced a major milestone in its long-standing partnership with NASA: the successful…

Read MoreAir Products Completes First Liquid Hydrogen Fill at World’s Largest Sphere at NASA
Kinea Bio Advances Dysferlinopathy Gene Therapy with $1.1M

Kinea Bio Advances Dysferlinopathy Gene Therapy with $1.1M Investment, Solid Biosciences Deal

Kinea Bio Inc., a biotechnology company dedicated to developing transformative genetic medicines, announced today two major milestones that significantly advance its lead gene therapy program for dysferlinopathy, a rare and debilitating neuromuscular disease. The company has secured a commitment of…

Read MoreKinea Bio Advances Dysferlinopathy Gene Therapy with $1.1M Investment, Solid Biosciences Deal
Immuto Secures $8M Seed 2 Funding, Partners

Immuto Secures $8M Seed 2 Funding, Partners with Daiichi Sankyo on Structural Surfaceomics

Immuto Scientific today announced the closing of an oversubscribed $8 million Seed 2 financing round alongside a new drug discovery collaboration with Daiichi Sankyo, a leading global pharmaceutical company. The funding and collaboration represent significant milestones for Immuto as it…

Read MoreImmuto Secures $8M Seed 2 Funding, Partners with Daiichi Sankyo on Structural Surfaceomics